Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
Conditions
Interventions
None listed
Sponsors
Tata Memorial Hospital Research Administrative Council
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with leukemia, lymphoma and myeloma on chemotherapy. 2. Age more than or equal to 15 years. 3. Patients with Febrile Neutropenia
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To predict the complications in high risk FN patients complication being defined as need for intensive care admission, need for mechanical ventilation, need for vasopressor support, renal failure, arrhythmias requiring treatment, confused/altered mental state, congestive cardiac failure, bleeding requiring transfusion or death. Timepoint: This will be studied till day 28 from the day of onset of the episode | — |
Secondary
| Measure | Time frame |
|---|---|
| The probability of isolating a drug resistant organism based on clinical, laboratory and hospital antibiogram at the baseline will be assessed.Timepoint: At the baseline;To predict the complications in low risk FN patients complication being defined as need for intensive care admission, need for mechanical ventilation, need for vasopressor support, renal failure, arrhythmias requiring treatment, confused/altered mental state, congestive cardiac failure, bleeding requiring transfusion or death.Timepoint: This will be studied till day 28 from the day of onset of the episode | — |
Countries
India
Contacts
Public ContactDr Hemanth Muthuluri
Tata Memorial Hospital
Outcome results
None listed